Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial

INTRODUCTION: In the UK and Ireland, severe and complex obesity is managed in specialist weight management services (SWMS), which provide multicomponent lifestyle interventions to support weight loss, and use of medication if available. Liraglutide 3 mg (LIRA 3 mg) is an effective weight-loss medica...

Descripción completa

Detalles Bibliográficos
Autores principales: Papamargaritis, Dimitris, Al-Najim, Werd, Lim, Jonathan, Crane, James, Lean, Mike, le Roux, Carel, McGowan, Barbara, O'Shea, Donal, Webb, David, Wilding, John, Davies, Melanie J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044994/
https://www.ncbi.nlm.nih.gov/pubmed/32060156
http://dx.doi.org/10.1136/bmjopen-2019-034137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044994/
https://www.ncbi.nlm.nih.gov/pubmed/32060156
http://dx.doi.org/10.1136/bmjopen-2019-034137

Ejemplares similares